- UroToday Home
- Recent Abstracts
- Urologic Oncology
Investigative Urology
In vitro and in vivo pharmacological profile of the selective β(3)-adrenoceptor agonist mirabegron in rats- Abstract
February 21, 2013
Protease-activated receptor 2 signaling upregulates angiogenic growth factors in renal cell carcinoma- Abstract
February 21, 2013
Oncogenic FGFR3 gene fusions in bladder cancer- Abstract
February 21, 2013
Diphtheria toxin-epidermal growth factor fusion protein DAB389EGF for the treatment of bladder cancer- Abstract
February 21, 2013
A(3) adenosine receptor mediates apoptosis in 5637 human bladder cancer cells by G(q) protein/PKC-Dependent AIF upregulation- Abstract
February 21, 2013
Blocking IL-10 enhances bacillus calmette-guérin induced T helper Type 1 immune responses and anti-bladder cancer immunity - Abstract
February 21, 2013
Fatty acid patterns and risk of prostate cancer in a case-control study nested within the European Prospective Investigation into Cancer and Nutrition - Abstract
February 21, 2013
Phycocyanin induces apoptosis and enhances the effect of topotecan on prostate cell line LNCaP - Abstract
February 21, 2013
Genomic and epigenomic alterations in prostate cancer - Abstract
February 21, 2013
STX2171, a 17β-hydroxysteroid dehydrogenase type 3 (17β-HSD3) inhibitor, is efficacious in vivo in a novel hormone-dependent prostate cancer model - Abstract
February 21, 2013
Genetic ablation of the tetraspanin Cd151 reduces spontaneous metastatic spread of prostate cancer in the TRAMP model - Abstract
February 19, 2013
PCA3 noncoding RNA is involved in the control of prostate-cancer cell survival and modulates androgen receptor signaling - Abstract
February 19, 2013
Custirsen (OGX-011): A second-generation antisense inhibitor of clusterin in development for the treatment of prostate cancer - Abstract
February 19, 2013
Protective effects of low calcium intake and low calcium absorption vitamin D receptor genotype in the California Collaborative Prostate Cancer Study - Abstract
February 19, 2013